Literature DB >> 17223489

Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II).

L Norgren1, W R Hiatt, J A Dormandy, M R Nehler, K A Harris, F G R Fowkes.   

Abstract

Mesh：

Year:  2007        PMID： 17223489     DOI： 10.1016/j.jvs.2006.12.037

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN： 0741-5214            Impact factor:   4.268


× No keyword cloud information.
  1005 in total

1.  Autologous bone marrow mononuclear cell therapy is safe and promotes amputation-free survival in patients with critical limb ischemia.

Authors:  Michael P Murphy; Jeffrey H Lawson; Brian M Rapp; Michael C Dalsing; Janet Klein; Michael G Wilson; Gary D Hutchins; Keith L March
Journal:  J Vasc Surg       Date:  2011-04-22       Impact factor: 4.268

2.  Gender differences in the prevalence and management of metabolic syndrome and its components in patients with peripheral artery disease.

Authors:  Raha Nael; Polly S Montgomery; Kristy J Scott; Steve M Blevins; Andrew W Gardner
Journal:  Angiology       Date:  2011-04-20       Impact factor: 3.619

3.  Heart disease and stroke statistics--2012 update: a report from the American Heart Association.

Authors:  Véronique L Roger; Alan S Go; Donald M Lloyd-Jones; Emelia J Benjamin; Jarett D Berry; William B Borden; Dawn M Bravata; Shifan Dai; Earl S Ford; Caroline S Fox; Heather J Fullerton; Cathleen Gillespie; Susan M Hailpern; John A Heit; Virginia J Howard; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; Diane M Makuc; Gregory M Marcus; Ariane Marelli; David B Matchar; Claudia S Moy; Dariush Mozaffarian; Michael E Mussolino; Graham Nichol; Nina P Paynter; Elsayed Z Soliman; Paul D Sorlie; Nona Sotoodehnia; Tanya N Turan; Salim S Virani; Nathan D Wong; Daniel Woo; Melanie B Turner
Journal:  Circulation       Date:  2011-12-15       Impact factor: 29.690

4.  Combined common femoral artery endarterectomy with superficial femoral artery stenting plus Shuxuening Injection infusion for chronic lower extremity ischemia: 3-year results.

Authors:  Hai Feng; Xue-ming Chen; Chen-yu Li; Ren-ming Zhu; Jie Fang; Tian-you Wang
Journal:  Chin J Integr Med       Date:  2012-04-11       Impact factor: 1.978

Review 5.  Clinical implications of skeletal muscle blood-oxygenation-level-dependent (BOLD) MRI.

Authors:  Sasan Partovi; Sasan Karimi; Bjoern Jacobi; Anja-Carina Schulte; Markus Aschwanden; Lisa Zipp; John K Lyo; Christof Karmonik; Matthias Müller-Eschner; Rolf W Huegli; Georg Bongartz; Deniz Bilecen
Journal:  MAGMA       Date:  2012-02-29       Impact factor: 2.310

6.  Adverse cardiovascular outcomes associated with concurrent use of clopidogrel or ticlopidine and proton-pump inhibitors in patients undergoing percutaneous coronary intervention.

Authors:  Atsuko Nakayama; Hiroyuki Morita; Jiro Ando; Hideo Fujita; Hiroshi Ohtsu; Ryozo Nagai
Journal:  Heart Vessels       Date:  2012-03-30       Impact factor: 2.037

7.  Despite normal arteriogenic and angiogenic responses, hind limb perfusion recovery and necrotic and fibroadipose tissue clearance are impaired in matrix metalloproteinase 9-deficient mice.

Authors:  Joshua K Meisner; Brian H Annex; Richard J Price
Journal:  J Vasc Surg       Date:  2014-02-28       Impact factor: 4.268

Review 8.  Epidemiology of limb loss.

Authors:  Priya Varma; Margaret G Stineman; Timothy R Dillingham
Journal:  Phys Med Rehabil Clin N Am       Date:  2014-02       Impact factor: 1.784

9.  Dual antiplatelet therapy is associated with prolonged survival after lower extremity revascularization.

Authors:  Peter A Soden; Sara L Zettervall; Klaas H J Ultee; Bruce E Landon; A James O'Malley; Philip P Goodney; Randall R DeMartino; Shipra Arya; Marc L Schermerhorn
Journal:  J Vasc Surg       Date:  2016-08-27       Impact factor: 4.268

10.  Associations between conventional cardiovascular risk factors and risk of peripheral artery disease in men.

Authors:  Michel M Joosten; Jennifer K Pai; Monica L Bertoia; Eric B Rimm; Donna Spiegelman; Murray A Mittleman; Kenneth J Mukamal
Journal:  JAMA       Date:  2012-10-24       Impact factor: 56.272
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.